Bora Pharmaceuticals Co., LTD. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 14,200.07 million compared to TWD 10,494.47 million a year ago. Net income was TWD 3,030.14 million compared to TWD 1,391.92 million a year ago.

Basic earnings per share from continuing operations was TWD 30.2 compared to TWD 14.26 a year ago. Diluted earnings per share from continuing operations was TWD 29.39 compared to TWD 14.13 a year ago.